Post-approval studies (Phase 4)Study completedNCT02660346What this trial is testingIL-10 Stratifying Tool for Towards Antibiotic Selection for MRSaBWho this might be right forBacteremia Sharp HealthCare 40
Not applicableActive Not RecruitingNCT07186894What this trial is testingCefazolin Versus Antistaphylococcal Penicillins for Methicillin Susceptible Staphylococcus Aureus BacteremiaWho this might be right forBacteriemiaMethicillin Susceptible Staphylococcus Aureus (MSSA) Infection Central Hospital, Nancy, France 5,000
Testing effectiveness (Phase 2)Looking for participantsNCT04886284What this trial is testingCombination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus BacteremiaWho this might be right forStaphylococcus Aureus BacteremiaStaphylococcus Aureus SepticemiaStaphylococcal Sepsis+1 more Todd C. Lee MD MPH FIDSA 60
Not applicableStudy completedNCT03248063What this trial is testingNon-inferiority Trial Comparing Cloxacillin vs Cefazolin in Methicillin-susceptible Staphylococcus Aureus BacteremiaWho this might be right forBacteremia Due to Methicillin Susceptible Staphylococcus Aureus Assistance Publique - Hôpitaux de Paris 315
Large-scale testing (Phase 3)Study completedNCT00093067What this trial is testingDaptomycin in the Treatment of Subjects With Infective Endocarditis or Bacteremia Due to S. AureusWho this might be right forBacterial EndocarditisBacteremia Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Post-approval studies (Phase 4)Looking for participantsNCT05137119What this trial is testingStaphylococcus Aureus Network Adaptive Platform TrialWho this might be right forStaphylococcus Aureus Bacteremia University of Melbourne 8,000
Not applicableLooking for participantsNCT06168474What this trial is testingEvaluating Simplified Layered Consent for Clinical TrialsWho this might be right forStaphylococcus Aureus Bacteremia Sunnybrook Health Sciences Centre 346
Not applicableLooking for participantsNCT06958835What this trial is testingLinezolid Plus Standard of CareWho this might be right forStaphylococcus Aureus Bloodstream Infections (BSI; Bacteremia) University Hospital, Basel, Switzerland 606
Testing effectiveness (Phase 2)Study completedNCT02357966What this trial is testingSafety & Efficacy of True Human Antibody, 514G3, in Staphylococcus Aureus Bacteremia Hospitalized Subjects.Who this might be right forStaphylococcus Aureus Bacteremia XBiotech, Inc. 52
Post-approval studies (Phase 4)Looking for participantsNCT06650501What this trial is testingDabigatran vs. Apixaban, Edoxaban, or Rivaroxaban as Anti-thrombotic Therapy in Patients With S. Aureus BacteremiaWho this might be right forStaphylococcus Aureus EndocarditisStaphylococcus Aureus SepticemiaStaphylococcus Aureus Bacteremia+3 more Emily McDonald 300
Not applicableNot Yet RecruitingNCT05361135What this trial is testing18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus BacteraemiaWho this might be right forStaphylococcus Aureus BacteremiaStaphylococcus Aureus SepticemiaSepsis Bacterial+4 more University College, London 820
Testing effectiveness (Phase 2)Ended earlyNCT01975662What this trial is testingVancomycin Versus Daptomycin for the Treatment of Methicillin Resistant Staphylococcus Aureus (MRSA) BacteremiaWho this might be right forBacteremia Due to Staphylococcus Aureus Singapore General Hospital 14
Testing effectiveness (Phase 2)Study completedNCT01911624What this trial is testingDirect Thrombin Inhibitors Versus LMWH in Staphylococcus Aureus BacteraemiaWho this might be right forStaphylococcus Aureus Bacteraemia Universitaire Ziekenhuizen KU Leuven 94
Large-scale testing (Phase 3)Ended earlyNCT04160468What this trial is testingDirect Lysis of Staph Aureus Resistant Pathogen Trial of ExebacaseWho this might be right forStaphylococcus Aureus BacteremiaStaphylococcus Aureus Endocarditis ContraFect 259
Post-approval studies (Phase 4)UnknownNCT03514446What this trial is testingSeven Versus Fourteen Days of Treatment in Uncomplicated Staphylococcus Aureus BacteremiaWho this might be right forStaphylococcus Aureus Bacteremia Thomas Benfield 284
Testing effectiveness (Phase 2)Study completedNCT00062647What this trial is testingTelavancin for Treatment of Uncomplicated Staphylococcus Aureus BacteremiaWho this might be right forGram-Positive Bacterial Infections Cumberland Pharmaceuticals 60
Not applicableStudy completedNCT02476487What this trial is testingThe Benefit of FDG PET CT in the Treatment Algorithm of Staphylococcus Aureus BacteremiaWho this might be right forStaphylococcus Aureus Bacteremia Rambam Health Care Campus 143
Large-scale testing (Phase 3)Looking for participantsNCT07253688What this trial is testingAdjunctive Rifampin for the Treatment of Prosthetic Valve Endocarditis Due to S. AureusWho this might be right forStaphylococcus Aureus EndocarditisProsthetic Valve Endocarditis Todd C. Lee MD MPH FIDSA 330
Early research (Phase 1)Study completedNCT03162250What this trial is testingStudy to Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Participants With Staphylococcus Aureus Bacteremia Receiving Standard-of-Care (SOC) AntibioticsWho this might be right forBacteremia Genentech, Inc. 27
Testing effectiveness (Phase 2)WithdrawnNCT05329168What this trial is testingERAdicate S. Aureus in Patients With Bacteremia and EndocarditisWho this might be right forBacteremia Due to Staphylococcus AureusLeft Sided Infective Endocarditis (Disorder)Right Sided Infective Endocarditis (Disorder)+1 more Lysovant